Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Novo Nordisk Stock Is Slipping Today

President Biden and Sen. Bernie Sanders warned the drugmaker against "ripping off the American people."

LLY : 906.71 (-0.84%)
NVO : 142.98 (-1.68%)
Surprise! Novo Nordisk's Wegovy Just Achieved Another Milestone. Here's What You Need to Know.

Wegovy was just approved in China.

NVO : 142.98 (-1.68%)
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

The market for weight loss medicines keeps getting hotter and hotter.

ALT : 6.74 (-6.39%)
NVO : 142.98 (-1.68%)
This Is Massive News for Eli Lilly Investors

A panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly's Alzheimer's candidate.

NVO : 142.98 (-1.68%)
BIIB : 228.82 (-1.27%)
LLY : 906.71 (-0.84%)
Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.

Eli Lilly is the latest major pharmaceutical company to bring artificial intelligence (AI) to the healthcare sector.

NVO : 142.98 (-1.68%)
NVDA : 122.67 (-1.31%)
LLY : 906.71 (-0.84%)
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

These healthcare stocks have clear paths to growth over the next few years.

LLY : 906.71 (-0.84%)
NVO : 142.98 (-1.68%)
VRTX : 473.78 (+0.54%)
VKTX : 51.54 (-6.83%)
TMDX : 148.97 (-0.81%)
1 Huge New Reason This Diet Drug Stock is a Must-Own

The recent announcement that China approved Novo Nordisk's Wegovy is huge. Here's why: In a national survey conducted during 2015-2019 by China’s National Health Commission, more than half of the adult...

NVO : 142.98 (-1.68%)
CTLT : 56.20 (+0.07%)
Better Growth Stock: Archer Aviation or Viking Therapeutics?

Which one of these potential disruptors is the better buy?

LLY : 906.71 (-0.84%)
NVO : 142.98 (-1.68%)
ACHR : 3.72 (+8.77%)
VKTX : 51.54 (-6.83%)
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?

This is a matchup that the latecomer might not be able to win.

PFE : 27.83 (-1.38%)
NVO : 142.98 (-1.68%)
Novo Nordisk’s Weight Loss Drug Approved In China

Novo Nordisk’s (NVO) weight loss drug “Wegovy” has been approved in China, opening a huge new market ...

NVO : 142.98 (-1.68%)

Barchart Exclusives

Is This Copper Mining Stock a Buy for Its Fat Dividend?
Southern Copper has a higher dividend yield compared to other copper mining companies. However, its valuations are also on the higher side, making a closer examination of the risk-reward necessary for prospective investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar